Cardiac stunning as a manifestation of ATRA differentiation syndrome in acute promyelocytic leukemia.
Hematology Division, Department of Internal Medicine, Medical School of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil. gil@hemocentro.fmrp.usp.br
Gil C
GC
De Santis
Maria Isabel A
MI
Madeira
Luciana C O
LC
de Oliveira
Roberto P
RP
Falcao
Eduardo M
EM
Rego
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D017023:Coronary Angiography; D004452:Echocardiography; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D017682:Myocardial Stunning / Q000139:chemically induced* / Q000503:physiopathology; D013577:Syndrome; D014212:Tretinoin / Q000009:adverse effects*
D000970:Antineoplastic Agents; D014212:Tretinoin
Semin Hematol. 2001 Jan;38(1):13-25
11172536
Interact Cardiovasc Thorac Surg. 2010 Jan;10(1):86-91
19773228
Best Pract Res Clin Haematol. 2003 Sep;16(3):419-32
12935960
Acta Haematol. 1997;97(4):228-30
9158667
Rinsho Ketsueki. 2002 Oct;43(10):954-9
12462033
Blood. 2009 Apr 23;113(17):3911-7
19088376
Haematologica. 2007 Dec;92(12):1615-22
18055984
Blood. 1998 Oct 15;92(8):2712-8
9763554
Thromb Res. 2005;115(1-2):59-64
15567454
Leukemia. 2007 Jan;21(1):79-83
16932337
Blood. 2009 Jan 22;113(4):775-83
18945964
Hematology Am Soc Hematol Educ Program. 2006;:147-55
17124054
Nat Rev Cardiol. 2010 Apr;7(4):187-93
20195267